Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabella Hausle

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging InitiativeAlper Gel, Eliana Phillips, Isabella Hausle, et al.
Frontiers in Neuroscience|April 17, 2026
Spatial coupling of enlarged perivascular spaces and white matter lesions across the Alzheimer's disease continuumSerena Tang, Pamela Thropp, Isabella Hausle, et al.
The Journal of Prevention of Alzheimer'S Disease|June 17, 2026
The time interval from amyloid to tau PET positivity varies by age, sex and APOE-ε4 statusMarta Milà-Alomà, Isabella Hausle, Kellen K Petersen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Temporal sequence of amyloid and tau PET positivity: <i>APOE</i> -ε4 and sex effects, and implications for Alzheimer's disease progressionMarta Milà-Alomà, Isabella Hausle, Kellen K Petersen, et al.
The Journal of Prevention of Alzheimer'S Disease|November 24, 2025
Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performanceAlison Myoraku, Isabella Hausle, Marta Mila-Aloma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 27, 2026
Sex differences in Alzheimer's disease plasma biomarker levels and clinical utilityMarta Milà-Alomà, Isabella Hausle, Alison Myoraku, et al.
Annals of Neurology|June 20, 2025
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET ClocksMarta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
MCH-Guard: Multimodal Machine Learning Framework for Risk Stratification of Cerebral Microhemorrhage Risk in the Alzheimer's Disease Neuroimaging InitiativeAlper Gel, Eliana Phillips, Isabella Hausle, et al.
Frontiers in Neuroscience|April 17, 2026
Spatial coupling of enlarged perivascular spaces and white matter lesions across the Alzheimer's disease continuumSerena Tang, Pamela Thropp, Isabella Hausle, et al.
The Journal of Prevention of Alzheimer'S Disease|June 17, 2026
The time interval from amyloid to tau PET positivity varies by age, sex and APOE-ε4 statusMarta Milà-Alomà, Isabella Hausle, Kellen K Petersen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Temporal sequence of amyloid and tau PET positivity: <i>APOE</i> -ε4 and sex effects, and implications for Alzheimer's disease progressionMarta Milà-Alomà, Isabella Hausle, Kellen K Petersen, et al.
The Journal of Prevention of Alzheimer'S Disease|November 24, 2025
Association of neighborhood disadvantage with Alzheimer's disease pathology and the stability of blood-based biomarker performanceAlison Myoraku, Isabella Hausle, Marta Mila-Aloma, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 27, 2026
Sex differences in Alzheimer's disease plasma biomarker levels and clinical utilityMarta Milà-Alomà, Isabella Hausle, Alison Myoraku, et al.
Annals of Neurology|June 20, 2025
Timing of Changes in Alzheimer's Disease Plasma Biomarkers as Assessed by Amyloid and Tau PET ClocksMarta Milà-Alomà, Duygu Tosun, Suzanne E Schindler, et al.
Pageof 1